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Abstract
Background
Reaching an acceptable participation rate in screening programs is challenging. With the
objective of supporting the Belarus government to implement mammography screening as
a single intervention, we analyse the main determinants of breast cancer screening
participation.
Methods
We developed a discrete choice experiment using a mixed research approach, comprising a
literature review, in-depth interviews with key informants (n = 23), “think aloud” pilots (n =
10) and quantitative measurement of stated preferences for a representative sample of
Belarus women (n = 428, 89% response rate). The choice data were analysed using a latent
class logit model with four classes selected based on statistical (consistent Akaike informa-
tion criterion) and interpretational considerations.
Results
Women in the sample were representative of all six geographic regions, mainly urban
(81%), and high-education (31%) characteristics. Preferences of women in all four classes
were primarily influenced by the perceived reliability of the test (sensitivity and screening
method) and costs. Travel and waiting time were important components in the decision for
34% of women. Most women in Belarus preferred mammography screening to the existing
clinical breast examination (90%). However, if the national screening program is restricted
in capacity, this proportion of women will drop to 55%. Women in all four classes preferred
combined screening (mammography with clinical breast examination) to single mammogra-
phy. While this preference was stronger if lower test sensitivity was assumed, 28% of
women consistently gave more importance to combined screening than to test sensitivity.
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Conclusion
Women in Belarus were favourable to mammography screening. Population should be
informed that there are no benefits of combined screening compared to single mammogra-
phy. The results of this study are directly relevant to policy makers and help them targeting
the screening population.
Introduction
Breast cancer is the most common cancer in women worldwide, and breast cancer screening
(BCS) programs via mammography are frequently established in an effort to decrease mortal-
ity. Reaching high screening uptake is challenging to achieve. Only half of the BCS programs
in European Union reached the benchmark of acceptable participation (>70%) [1]. Besides,
informed by the ongoing debates on the benefits/harms ratio of BCS [2], women invited to the
new screening programs may be negatively affected by the risk of false-positive result of the
test and overdiagnosis [3]. This fear of screening-related harms may avert their preferences
from BCS in general or shift them towards programs with lower risk of harms from a popula-
tion perspective (e.g. more qualified doctors, specialized or private hospitals, etc.).Therefore,
implementation of any BCS requires a deep insight into population preferences for screening
strategies and their characteristics before nation-wide program implementation.
There is limited knowledge about women’s preferences to BCS; these preferences are
impacted by cultural and social barriers, including cultural norms, socio-economic status and
gender equality index. Thus, the screening preferences will vary among culturally—diverse
jurisdictions [4, 5]. Meanwhile, the literature on preferences to BCS among women from low-
and middle-income settings is scarce, particularly the documentary sources pertaining to Cen-
tral and Eastern Europe [6].
The Republic of Belarus (henceforth Belarus) is a middle-income country in Eastern
Europe with population of 9.5 million people and total gross domestic product of 188 billion
USD (2018) [7]. Since its independence in 1991, Belarus maintained an opportunistic clinical
breast examination (CBE) program as part of an annual physical examination. In 2014 the gov-
ernment of Belarus launched several pilot projects aimed at introducing nationwide mammog-
raphy screening for 50–69 year old women [8]. The mammography screening is provided to
the population free of charge similar to the other health services, and the BCS program escala-
tion is planned after proper evaluation of the pilots [9].
Considering the desire of the government in Belarus to implement a nationwide mammog-
raphy screening, we aimed to support this intention by defining the design of the BCS pro-
grams that would get more support from the target population. To do this, we set an objective
to assess women’s preferences for the BCS programs using discrete choice experiment (DCE)
on a representative sample of women in Belarus. We also aim to demonstrate how providers of
BCS services can use empirical findings to develop preferred participation strategies.
Methods
Planning the discrete choice experiment
Multiple approaches towards evaluation of respondents’ preferences have been developed
through the years. One of them, DCE, is a well-established and Nobel-prize winning prefer-
ence elicitation technique with a theoretical and behavioural foundation in Random Utility
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Theory (RUT). RUT assumes that goods and services can be described by their characteristics
(called “attributes” in a DCE) and different values of these characteristics (called “levels” in a
DCE). By applying the DCE one considers that any health intervention can be described by a
combination of levels and that consumer’s utility for these interventions is a function of a com-
bination of these characteristics [10–12]. The strength of DCEs is that they focus on utilities of
characteristics of an intervention rather than the general utility of intervention. By doing this,
it allows researchers to evaluate preferences of a population to a hypothetical screening pro-
gram prior to its implementation, and so supports the development of a better and more suc-
cessful screening design prior to the actual implementation.
Designing a DCE involves a process of developing, testing and optimizing the experiment
questionnaire. To develop a DCE a mixed research approach was used, comprising a literature
review, exploratory in-depth interviews with the key informants (n = 23), “think aloud” (TAL)
pilots of the instrument (n = 10) and quantitative measurement of stated preferences. The pro-
tocol and relevant study materials were developed in English, then translated into Russian and
verified by the second co-author. Ethics approval of the research protocol was obtained from
the International Agency for Research on Cancer (17–11) and N.N. Alexandrov National Can-
cer Center of Belarus (138).
Selection of attributes and levels
The selection of attributes and levels was based on a step-wise bottom-up approach. As a first
step, through an extensive literature review of PubMed, Embase, Scopus and the regional data-
bases (IMSEAR, Index Medicus for the Eastern Mediterranean Region, LILAC/IBECS) in
English, Russian, French, Portuguese and Spanish languages we identified 383 abstracts which
led to inclusion of 34 full-texts (refer to the S1 File for the detailed protocol including the
search strategy and the results). Content analysis of this literature using Atlas.ti software iden-
tified 21 plausible factors impacting the decision of women to attend BCS in low- and middle-
income countries (Table 1).
The factors grouped under the framework as procedure-related, organization-related or
provider/population-related, were used to develop a semi-structured interview guide to test
their importance, relevance, and clarity of the concepts. Interviews lasting 50–90 minutes were
conducted until data saturation with three categories of key informants (n = 23): (1) healthcare
professionals of the pilot screening centers, (2) healthcare professionals not involved in screen-
ing, and (3) target population (50–69 year-old women who participated and did not participate
in screening mammography). The respondents were diverse by their age, number of years of
working experience, family state, frequency of healthcare use, level of education, and income.
Eight of the respondents were from rural areas while others fromMinsk city. The audio
Table 1. Factors affecting preferences for breast cancer screening: The results of the literature review.
Procedure Organization Population and provider
Approach: breast cancer detection strategy
and its frequency
Facility: type of facility where the test was preformed Personal attitude and beliefs of women
Discomfort: discomfort or pain during the
test, screening time
Affordability: screening costs, access to free treatment in case the disease is
identified)
Socio-demographic characteristics of
screened population
Clinical benefits: sensitivity and mortality
decrease
Invitation: waiting time to get test, comprehensive information, individual
instructions, and ways of screening announcement.
Health worker type or sex
Harms: specificity, overdiagnosis,
complication risk
Accessibility: location of test/ travel time, accessibility by public transportation
Convenience: possibility to combine the screening with the other health
programs, waiting time for the results
https://doi.org/10.1371/journal.pone.0224667.t001
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records were transliterated verbatim, validated, and analysed by the content analysis with
Atlas.ti software (the methodology is reported in the S2 File). All the steps of qualitative analy-
sis were either duplicated or verified by two researchers (OM, AY).
As a result of this phase we excluded the attributes consistently reported as not important
by the respondents (such as overdiagnosis, specificity, health worker sex, et al.), and those
reported by the respondents as not relevant for Belarus (free treatment in case the disease is
identified and accessibility of public transportation). We also added emerging themes from the
interviews: queue waiting time and knowing the doctor as a “good one”. The behavioral obser-
vations showed that the respondents had difficulty in perceiving mortality decreases from
screening; for this reason, screening sensitivity was selected to reflect the clinical benefit of the
test. We also found that some respondents had difficulty understanding the concepts of
“screening” and “sensitivity” of the tests. Thus, we developed introductory cards explaining
unfamiliar definitions and teaching the respondents the process of DCEs.
We used “think aloud” (TAL) techniques to test the perception and clarity of the developed
instrument, and test whether respondents considered all attributes listed when making their
choice. A TAL session requires participants to verbalize their thought process during the deci-
sion making. Applying the mix of concurrent and retrospective TAL approaches, we optimized
the visual design of the experiment (the font of the text and graphical location of the elements),
and values of the levels for test sensitivity attribute (refer to the S2 File for the details). The
final DCE design included 10 attributes described in the Table 2 with an example of the DCE
task presented on Fig 1.
Experimental design
DCEs require respondents to select the preferred sets of screening program attributes. The
combination of attributes and levels that respondents evaluate in a choice experiment survey is
referred to as the experimental design. Our experimental design was created using a Bayesian
D-efficient design optimization algorithm that was implemented in Fortran. The DCE design
consisted of four versions of 18 pairwise choice sets with 10 attributes each. These four
Table 2. Attributes and levels in the discrete choice experiment.
N Attributes Definition Levels
1 Way of invitation The approach a women prefers to be invited to screening Postal letter / Telephone call
2 Possibility to arrange the
appointment right away
Possibility to get the appointment arranged during the time of invitation (or
fixed-appointment scheme)
Yes / No
3 Comprehensive information about
screening
Receiving comprehensive information on breast cancer and screening during
the invitation
Yes / No
4 Total travel time Total travel time required for women to get from home to screening facility 20 minutes/ 40 minutes/ 60 minutes/ 90
minutes
5 Waiting time Waiting time in healthcare facility during the screening visit 20 minutes/ 40 minutes/ 60 minutes
6 Perception of the physician as “a
good doctor”
Perceiving the physician conducting the screening test as a “good” one, either
because of the personal previous experience or trusted recommendation
Yes / No
7 Screening modality Approach by which the breast cancer screening is conducted Manual examination/ Mammography /
Manually and by mammography
8 Test sensitivity Ability of the test to detect cancer when a woman has it 60% / 70% / 80% / 90%
9 Possibility to combine the screening
with other medical visits
Possibility to address several health issues within one visit to healthcare facility
(for example, another screening test)
Yes / No
10 Cost of the test Out-of-pocket costs of the screening (not reimbursed) 0 BRB / 20 BRB 1 / 40 BRB 1
1 34 ID and 68 ID using purchasing power parity 2017 exchange rate (0.59).
https://doi.org/10.1371/journal.pone.0224667.t002
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versions were simultaneously optimized, which improves the robustness and efficiency of the
experimental design without resulting in a higher burden for respondents [13]. To keep the
task complexity of the DCE manageable for respondents, which reduces the drop-out rate,
increases choice consistency, and can avoid problems with attribute non-attendance, a design
technique called attribute level overlap was used [14, 15]. Accordingly, in each choice task,
seven of the 10 attributes were constrained to be presented at the same level. To increase the
validity and realism of the DCE design, another design constraint was imposed to ensure that
the sensitivity of CBE could be either less or equally effective but not exceed the effectiveness
of mammography screening.
To reduce the required overall sample size and maximize the information obtained from
the pilot studies, the results of the qualitative group analysis and subsequently those of two
consecutive pilots with 40 and 150 women were used to generate the required Bayesian priors
for the design optimizations. The first two DCE designs were optimized for the average popu-
lation preferences but, after having obtained 190 respondents, the final DCE design was simul-
taneously optimized for the average population preferences as well the preferences obtained
using a 2-class (latent class) logit model. Combined with the Bayesian priors, this resulted in a
single DCE design that ensured statistical identification as well as optimal statistical efficiency
for respondents with potentially very different preference structures. Sample size calculations
as described by De Bekker-Grob et al. (2015) were used to verify identification and determine
the minimally required sample size [16]. Based on these calculations, approximately 400
respondents were required to have sufficient power to obtain statistically significant results for
preference parameters larger than or equal to 0.1.
Fig 1. An example of the discrete choice experiment task.
https://doi.org/10.1371/journal.pone.0224667.g001
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Study sample and survey administration
The study sample was stratified by share of urban and rural population and by the region of
enrolment to reflect geographical representation of 50–69 year-old women in Belarus. To
decrease the enrolment bias and and to ensure that the survey sample was representative by
age, income, and employment status, all respondents were recruited in traumatology and burn
departments of hospitals in Minsk, Brest, Vitebsk, Gomel, Grodnensk, and Mogilevsk regions.
The women were enrolled if they were 50–69 years old, capable of understanding and commu-
nicating in the Russian language, provided verbal and written informed consent, and were on
a recovery stage in their hospitalization. Women were excluded if they refused participation in
the study or if they were considered by the interviewer incapable of formulating clear phrases
and sentences verbally and in writing, had a recent history of serious breast diseases, or were
hospitalized with a diagnosis that could is associated with a higher risk of breast cancer (for
example, traumas related to high alcohol consumption). A written informed consent was
received from each study participant prior to the interview. The process of data collection and
quality control, including interviewers’ training, is presented in the S3 File.
The survey was structured as follows. First, it started with an introduction that explained
the interview approach and necessary concepts, followed by a short exercise in making choices
on common consumer goods (preferable fruits and telephones). To reduce the fatigue from
repetitive choices, we presented the DCE in two sets of eight and ten choice tasks, with a few
demographic questions included in between and with a brief health attitude survey using
Likert scale statements at the end. The attitude survey included questions on beliefs in success
of treatment of early detected breast cancer, fatalistic approach, and personal risk (S4 File). All
the paper & pencil forms were double-entered into the database and compared for
inconsistencies.
Analysis
A latent class logit (LCL) model was used to explore respondents’ preferences for BCS. The
model was chosen as the most appropriate to develop policy recommendations for different
population groups rather than a single heterogeneous population. A LCL model assumes that
there are c distinct sets (or classes) of respondents. Each class has its own preference parame-
ters (i.e. Č = Č1, Č2, .. , Čc), which implies that preferences are assumed homogeneous within
each class but allowed to be different between classes. Respondents are thus grouped based on
their preferences rather than pre-specified background characteristics [17].
The optimal number of classes was determined based on a comparison of Bayesian infor-
mation criterion (BIC) and consistent Akaike information criterion (CAIC) for LCL class solu-
tions ranging from two to seven classes. After having determined the optimal number of
classes, it was verified that the results were internally consistent with adequate face validity.
Additionally, the average posterior probability of individual-level class-membership was calcu-
lated to obtain a quantitative measure of the quality of class-membership prediction [17].
Policy scenarios
After having obtained the preference estimates, standard conditional logit choice share predic-
tions were used, for each of the latent classes, to predict the BCS uptake for different policy sce-
narios (S5 File):
a. between the existing program with CBE and screening mammography pilots;
b. between population-wide screening mammography considering possible capacity con-
straints and CBE program;
Breast cancer screening preferences
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c. between hypothetical screening program in private hospitals and screening mammography
pilots.
The policy scenarios were informed by the medical staff involved in screening and target
population during development of the experiment (n = 23) (for the description of the sample
please refer to “2.1. Selection of attributes and levels” and S2 File). CBE in Belarus is conducted
at annual visits of women to the district gynecologists, and so it assumes a low waiting and travel
time, familiarity with the physician, and possibility to combine the screening visits with other
health reasons. The pilot mammography program is limited in geographic coverage; since cur-
rent capacity is underused, the participants are actively invited both by calls and mail, and do
not have long waiting time. Some women attending screening receive CBE prior to mammogra-
phy. The National mammography program assumed possible capacity constrains (and so addi-
tional waiting and travel times) because of higher attendance rate of target population.
Considering that accuracy of screening is an overlapping parameter in screening programs,
we excluded it from the list of attributes in policy assessments. We conducted sensitivity analy-
ses to assess an impact of accuracy of mammography and perception of “better physicians” in
private hospitals on population preferences.
Results
Selecting the right attributes: Qualitative results
In-depth interviews with 23 women allowed to select 10 attributes that would affect the
respondents’ stated decision to attend BCS. As such, we excluded the attributes that were:
a. Consistently reported as not important by the respondents to the extend being possible to
affect the decision of the respondent to participate in screening (such as overdiagnosis, risk
of radiation exposure, false positive results or screening test specificity, health worker sex,
waiting time to get test results, test frequency, complication risk, individual versus group
instructions, and type of healthcare facility);
b. Considered by the respondents as not relevant for Belarus (such as an access to free treat-
ment and accessibility by public transportation).
For instance, while the respondents wanted to be informed on screening related harms,
none of these harms (within the ranges reported in systematic reviews [2]) affected their stated
decision to participate in a program when the definitions of harms were explained to the
respondent and correctly repeated back to the interviewer. In particular, in reasoning their
choices women stated that:
a. Radiation exposure with mammography screening is minimum comparatively to the other
experiences (meaning Chernobyl explosion and an obligatory annual X-ray for all working
population);
b. False-positive test results are not important since the correct diagnosis will be revealed with
the future investigation;
c. Overdiagnosis would not affect the screening decision since a woman would not be able to
know if she is overdiagnosed or not.
Description of the study participants
From 490 women invited, 434 agreed to participate and 428 completed the entire survey
(resulting in 89% response and 1.4% drop-out rate). The geographical distribution of the
Breast cancer screening preferences
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enrolled population (150 in Minsk, 64 in Brest, 55 in Vitebsk, 65 in Gomel, and 50 in Grod-
nensk and Mogilevsk respectively) as well as the proportion of urban versus rural population,
and population with university education or above was representative in Belarus [18]. The
descriptive statistics of enrolled population are presented in the Table 3. More than half of the
respondents knew at least someone who had a medical history of breast cancer, with 15% of
women having a relative with the history of this disease. Around two thirds of women had a
BCS visit during the last year. Additionally, almost half of the women at least once in a lifetime
received mammography.
Regarding breast cancer perception, 64% of women believed that treatment of early-
detected breast cancer has a high probability of success. At the same time, 15% and 13% of
women respectively reported agreement with the statements “I will never get sick to breast
cancer” or “I don’t want to know about the diagnosis if I have cancer”, while only 7% of
women considered their breast cancer risk to be higher than of the other women. Almost half
of women (49%) stated that they do not postpone addressing for healthcare services when they
have any health issues.
Relative attribute importance in the different latent classes
The latent class logit model with four classes was selected by the CAIC coefficient, selecting the
point where adding additional latent classes no longer contributed to a meaningfully lower
value (CAIC 2 Latent classes = 13,112, CAIC 3 Latent classes = 12,929, CAIC 4 Latent clas-
ses = 12,769, CAIC 5 Latent classes = 12,766). The opt-out option was selected in 19% of all
Table 3. Characteristics of the enrolled population.
Characteristics Categories Number of women (%)
Healthcare users (number of visits/last 6 months)1 Rare (0) 79 (18%)
Average (1–4) 260 (60%)
Frequent (> 4) 92 (22%)
Use paid healthcare services Within the last 6
months
120 (28%)
Have relative(s) with breast cancer Yes 65 (15%)
Have acquaintance(s) with breast cancer Yes 235 (55%)
Was screened within the last 12 months Yes 302 (70%)
Have experience with mammography Yes 200 (46%)
Practice breast self-examination (at least once during 3
months)
Yes 263 (61%)
Live alone Yes 101 (23%)
Are employed Full day 262 (61%)
Partially 20 (5%)
Doesn’t work 147 (34%)
Have university degree or above Yes 132 (31%)
Live in the city/town Yes 350 (81%)
Have low-income2 Yes 157 (36%)
Are aged, years 50–54 142 (33%)
55–59 137 (32%)
60–64 77 (18%)
65–69 17%)
1 Not including the current hospitalization
2 Family income is less than 500 BYR (848 ID) per month
https://doi.org/10.1371/journal.pone.0224667.t003
Breast cancer screening preferences
PLOS ONE | https://doi.org/10.1371/journal.pone.0224667 November 1, 2019 8 / 17
scenarios among all latent classes. While second and third latent classes were quite similar in
their prediction, we selected this model to reach the optimal statistical results. The results of
the latent class model with three classes are presented in the S1 Table.
Class-membership prediction versus fourth class showed statistically significant difference
in a proportion of frequent healthcare users in the first and third classes, proportion of women
living alone in all three classes, proportion of women with previous mammography experience
(lifetime experience) in the second and third classes, and proportion of women frequently
practicing breast self-examination in the second class. The socio-demographic characteristics
of population (education, employment state, place of habitation) could not predict the mem-
bership to the particular latent class; therefore, we report the model with no covariates.
The estimated coefficients in the model were significant in most cases. The signs of the coef-
ficients were, conform expectations, negative for time, costs, and “doctor trust” components
(meaning that women preferred the BCS programs free of charge, with low waiting and travel
time, and knowing that the screening physician is a “good one”), and positive for all the other
attributes (Table 4). Women in all four classes were primarily affected by the perceived reliabil-
ity of the text (sensitivity and screening method) and costs (Table 4).
The first class represented the largest share of the respondents (56%). Besides the main driv-
ers—perceived reliability and costs—the respondents’ choices in the first class were impacted
by having trust in a physician, receiving detailed information, and possibility to combine their
screening visit with other visits to healthcare facility. Women in second class (16% of popula-
tion) had just a few factors important besides perceived test reliability and costs, mainly related
to waiting and travel time. For women in the third class (18%) perceived reliability of screening
was important much less than for women in other classes, though they were also concerned by
the convenience factors (travel and waiting time, being invited by telephone call, being able to
combine screening with other healthcare visits, and having a trusted doctor). The fourth class
included only 10% of the respondents. This group was not sensitive to any other factors besides
costs, perceived reliability and screening information. While this group is in general support-
ive to screening, it is very price sensitive.
Preferences to policy scenarios
The results of the assessment of population preferences to three policy scenarios are reported
in the Table 5.
Women in Belarus had strong preferences for pilot mammography program comparing to
existing CBE (90% on average). The lowest preference for the pilot screening mammography
versus CBE was among women in the first latent class (86%), versus up to 92–99% among
women in the other three classes. In a sensitivity analysis assuming 70% sensitivity of mam-
mography versus 60% sensitivity of CBE, the preference for the latter increased to 95–100% in
all four classes, while with sensitivity of 80% the preference reached 98–100%.
If the capacity constraints (such as only non-combined mammography would be available,
travel and waiting time will increase, and women are invited by mail) affect the mammography
screening program during its expansion to a nation-wide level, this would primarily affect the
first, third and fourth latent classes where only 55%, 30% and 51% of women would prefer
screening mammography under such conditions resulting to 55% of women on average pre-
ferring such screening program comparing to CBE.
A hypothetical scenario where private clinics (assuming a short waiting time, immediate
appointment, and combined mammography with CBE) would be also included into the sys-
tem of the national healthcare screening, would be of particular interest to women in the first
and third latent class (47% and 36% of respondents would prefer this policy scenario to pilot
Breast cancer screening preferences
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Table 4. Results of the latent class model.
Attributes Latent Class 1 Latent Class 2 Latent Class 3 Latent Class 4
Utility SE P 95% CI Utility SE P 95% CI Utility SE P 95% CI Utility SE P 95% CI
Telephone invitation (vs. mailed
letter)
0.131 0.080 0.104 -0.027 0.289 -0.239 0.12 0.231 -0.63 0.152 0.774 0.168 0.000 0.444 1.104 0.207 0.192 0.281 -0.169 0.583
Being able to get the appointment
right away (vs. being instructed
how to do it)
0.179 0.083 0.031 0.016 0.341 0.054 0.146 0.713 -0.232 0.339 -0.117 0.119 0.322 -0.350 0.115 0.033 0.172 0.848 -0.304 0.369
Detailed information on
screening (vs. no information)
0.500 0.103 0.000 0.299 0.702 0.373 0.157 0.017 0.065 0.680 0.189 0.119 0.113 -0.044 0.421 -0.687 0.211 0.001 -1.101 -0.273
Possibility to combine screening
with other health visits (vs. no
possibility)
0.841 0.106 0.000 0.634 1.049 0.0821 0.167 0.623 -0.246 0.410 0.511 0.123 0.000 0.27 0.752 -0.0261 0.187 0.889 -0.393 0.341
Travel time 40 min (vs. 20 min) -0.1828 0.075 0.015 -0.329 -0.036 -0.303 0.160 0.059 -0.617 0.011 -0.267 0.134 0.046 -0.529 -0.005 -0.391 0.209 0.061 -0.801 0.019
Travel time 60 min (vs. 20 min) -0.079 0.085 0.352 -0.246 0.087 -0.998 0.181 0.000 -1.352 -0.644 -1.352 0.166 0.000 -1.677 -1.027 -0.006 0.225 0.997 -0.447 0.434
Travel time 90 min (vs. 20 min) -0.493 0.090 0.000 -0.671 -0.316 -2.180 0.215 0.000 -2.6 -1.758 -2.018 0.232 0.000 -2.472 -1.563 -0.002 0.231 0.992 -0.456 0.451
Waiting in the queue 40 min (vs
20 min)
0.043 0.090 0.635 -0.134 0.220 -0.323 0.159 0.042 -0.634 -0.012 -0.513 0.128 0.000 -0.763 -0.263 0.145 0.212 0.494 -0.270 0.560
Waiting in the queue 60 min (vs
20 min)
-0.060 0.081 0.455 -0.219 0.098 -0.737 0.205 0.000 -1.138 -0.335 -1.391 0.178 0.000 -1.74 -1.042 0.121 0.211 0.567 -0.293 0.536
Not knowing the doctor as “good”
(vs knowing)
-0.652 0.080 0.000 -0.808 -0.496 -0.128 0.145 0.377 -0.412 0.156 -0.384 0.121 0.001 -0.62 -0.148 -0.479 0.205 0.019 -0.881 -0.078
Screening by mammography (vs.
manual examination)
1.458 0.12 0.000 1.224 1.693 2.104 0.251 0.000 1.611 2.596 1.402 0.239 0.000 0.934 1.87 1.626 0.443 0.000 0.759 2.494
Screening by mammography and
manual examination (vs. manual
examination)
1.853 0.129 0.000 1.600 2.106 2.422 0.293 0.000 1.848 2.997 1.874 0.251 0.000 1.381 2.367 1.778 0.475 0.000 0.847 2.708
Sensitivity of the test is 70% (vs
60%)
1.098 0.103 0.000 0.896 1.300 1.442 0.236 0.000 0.980 1.904 0.685 0.195 0.000 0.303 1.067 0.730 0.292 0.012 0.158 1.302
Sensitivity of the test is 80% (vs
60%)
2.131 0.120 0.000 1.895 2.367 2.435 0.282 0.000 1.881 2.988 1.418 0.208 0.000 1.012 1.825 1.451 0.400 0.000 0.667 2.236
Sensitivity of the test is 90% (vs
60%)
3.002 0.160 0.000 2.689 3.314 3.614 0.328 0.000 2.970 4.257 1.600 0.224 0.000 1.159 2.037 1.597 0.451 0.000 0.713 2.48
Cost of the test is 20 BRB (vs 0
BRB)
-0.936 0.086 0.000 -1.104 -0.768 -0.426 0.16 0.000 -0.740 -0.112 -0.907 0.142 0.000 -1.186 -0.629 -3.188 0.263 0.000 -3.703 -2.673
Cost of the test is 40 BRB (vs 0
BRB)
-1.658 0.104 0.000 -1.863 -1.454 -2.187 0.231 0.000 -2.640 -1.733 -1.158 0.162 0.000 -1.476 -0.839 -5.514 0.500 0.000 -6.494 -4.534
Opt out -0.841 0.200 0.000 -1.233 -0.450 2.194 0.528 0.000 1.158 3.229 2.452 0.470 0.000 1.530 3.374 0.259 0.784 0.741 -1.278 1.796
Abbreviation: BRB–Belarus Rubbles; CI–confidence interval, P–probability; SE–Standard error.
https://doi.org/10.1371/journal.pone.0224667.t004
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screening mammography), though none of women in the fourth class and only 16% of the sec-
ond class would prefer this option. On average, 35% of women would prefer this option to
screening in public setting while 57% of women would prefer mammography screening at pri-
vate clinics to CBE. In a sensitivity analysis assuming higher sensitivity of mammography in
private versus public clinics (90% versus 80%), the preference to screening at private clinics
increased to 38–68% in the first three latent classes. If we assume that population has higher
trust in mammologists working in private clinics (the attribute “familiarity with the doctor”),
the preference to private clinics will be higher in the first and third latent classes (63% and 45%
respectively).
In all four classes women preferred combined screening (mammography with CBE) versus
mammography as the only intervention. The importance of screening modality was higher
with lower sensitivity of screening. When sensitivity was more than 80%, women on average
gave more importance to sensitivity rather than screening approach, though women of third
and fourth latent classes (28%) gave more importance to combined screening even with the
stated sensitivity of test in 90% (Fig 2).
Discussion
Our study showed that women in Belarus preferred mammography as a BCS program: 86–
99% of the sample predicted to choose this approach instead of existing CBE. Applying a DCE
to analyse women’s preferences for BCS we demonstrated that the respondents are highly sen-
sitive to perception of the accuracy of screening. The importance of subjective characteristics
Table 5. Policy scenarios.
Levels Current program
(CBE)
Pilot MM
(Minsk)
National MM
screening1,2
Paid
optimal2
Invitation by the post Letter Y Y N
Invitation by the post telephone Call Y Y N Y
Instructions on how to make an
appointment
Y Y Y Y
Opportunity to arrange your appointment
right away
N N N Y
No explanation about the process, effects
and risk of the program
Y Y N N
A clear explanation about the process,
effects, and risks of the program
N N Y Y
Visit is related only to early detection of
breast cancer
N Y Y N
Visit may be combined with other health
visits
Y N N Y
Average travel time, min 20 20 40 20
Average waiting time, min 20 20 40 20
Unknown doctor N Y Y Y
Screening by manual examination Y N N N
Screening by mammography N Y Y Y
Screening manually and by mammography N Y N Y
Price of the screening (ID 2018) 0 0 0 68
Abbreviations: CBE–clinical breast examination; ID–International dollars; MM–mammography; N–no, Y–Yes.
1Population-wide screening with considered capacity restriction caused by screening expansion
2Hypothetical screening that could potentially be implemented within private hospitals
https://doi.org/10.1371/journal.pone.0224667.t005
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Fig 2. Utility of screening method and test sensitivity. (a) Screening mammography as a solo intervention, (b) Screening mammography in
combination with clinical breast examination. LC–latent class, MM–mammography.
https://doi.org/10.1371/journal.pone.0224667.g002
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of accuracy (screening modality) in stated choice of women was lower with higher values of
objective factors (sensitivity of screening). The respondents’ preferences for BCS were also
highly sensitive to its costs. Systematic reviews of randomized and observational studies have
also confirmed an impact of removal of financial barriers on increase in BCS participation rate
[19–21]. While BCS in Belarus is free of charge, the target population should be familiar with
screening accessibility not to perceive it as an attendance barrier.
At the same time, among the population of 50–69 year old women around 75% was sensi-
tive to organizational characteristics of screening, such as possibility to combine their screen-
ing with other health visits, getting detailed information on screening, being invited by a
phone call, or having a trusted doctor. Besides, one-third of women are sensitive to time
parameters. This can become a concern when screening will be extrapolated from pilots to a
nation-wide level, and capacity constrains could result in travel requirements and waiting
lines. While screening centres are easily accessible within the cities, the access to health facili-
ties for rural inhabitants is more restricted and can decrease attendance rate among the most
deprived individuals who are of the higher risk for breast cancer mortality [22]. These results
are mainly consistent with the other studies using the same approach to evaluate preferences
to cancer screening [3,6, 23, 24]. The latent class model with four classes was able to improve
segmentation of respondents into groups with similar preferences. While cost was a significant
attribute in all four classes, using the latent class analysis allowed us to identify the subgroup of
women (around one tenth of population) for whom the costs and perceived reliability of
screening were the only influential factors,—this population could not be distinguished using
mixed logit model.
By comparing the other classes to this subgroup, we identify that women the most affected
by capacity constraints (third latent class) would have a higher number of frequent healthcare
users, livings alone and with experience of previous mammography. Systematic reviews dem-
onstrated an impact of positive or negative experience with mammography screening on wom-
en’s attendance decision [19, 20, 25]. Thus, women participating in DCE could be impacted by
factors affected their previous screening visit. Being married was associated with higher re-
attendance rate in the review of Soler-Michel, 2005 [20]; similarly in our study the women in
the fourth latent class, were in general positive about screening and had statistically different
proportion of women living with the families, comparing to the other three classes. The
reviews consider no or limited effect of being a frequent medical user on BCS attendance rate
[19,20]; the difference in high healthcare use in the first and third versus fourth latent classes
could be related to the opportunity costs considered by the respondents or to the chance
findings.
Another observation of our study is that women in Belarus are in general favourable to
screening: most of them stated the desire to participate if screening is highly effective and free.
The population is also favourable to mammography, considering it more effective than CBE.
Even more women prefer a combined program of screening mammography with CBE, which
for some women (28%) is even more important than stated sensitivity of screening. This find-
ing could be explained by an impact of personal beliefs on perceived effectiveness of screening,
e.g. “the more services the better the effect”, what is in line with the findings in other studies
on women’s perception related to cancer screening [26,27]. Another possible explanation
could be related to feeling by the respondents the more personalised attitude with the com-
bined screening (women, 53: “if the doctor touched my breast, it shows he cares”). While sub-
stantial evidence confirms no impact on breast cancer mortality decrease in screening with
CBE combined with mammography comparing to mammography as the only intervention
[28,29], through in-depth interviews we identified that some women believe in better detection
of cancer with combined screening or value the combined screening as a more personalised
Breast cancer screening preferences
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approach. Similarly, the utility values of combined screening were higher than for screening
mammography proposed as the only intervention in all latent classes. If screening mammogra-
phy as the only screening intervention is provided, the target population should be well
informed that the supplement screening approach would not improve screening accuracy.
Belarus has a taxation based decentralized healthcare system. The private sector expendi-
tures of health equal to 29% of total health expenditures [30], and are mainly related to out-of-
pocket payments [30] (mainly for drugs, but also related to paid services in public health cen-
tres). Besides, private market of diagnostic centres, functioning on fee-for-service bases, is
highly developed in the country [30]. Our results predict that this private network could be
included into the national screening program. Even though medical help in Belarus is widely
accepted as free of charge, almost one third of the respondents used paid services at least once
during the last six months. Our policy scenarios showed that if private hospitals are able to
provide more individual-based approach (such as better explanations on screening, combining
mammography with CBE, and the screening visit with other health visits), some women
would prefer to attend these facilities. Considering that a large proportion of patients already
choose to pay for diagnostic tests, attracted by advertisements and pleasant environment [30],
the policy implication of our finding would encourage use of paid services in public and pri-
vate health establishments.
While in general our findings are similar to those in other countries, we also observed some
striking differences in the results. First of all, in contrast to Sicsic et al (2018)[3], our explor-
atory part revealed a consistent undervalue of harms, such as overdiagnosis, radiation expo-
sure and false-positive outcomes of the screening test, to the extent that none of these
characteristics was significant to be included into the experiment. The online survey of 1,000
respondents has showed that acceptability of overdiagnosis in cancer screening is variable and
significantly higher for breast than bowel cancer, though lower for people aged 50 or over [21].
In our qualitative part of the study we recorded that while women were willing not know
about overdiagnosis, the rate of overdiagnosis did not impact their stated preferences to attend
the screening, if women understood the concept well.
Similarly, in contrast to the other DCE research on preferences to attributes of BCS in
Malawi [24], neither health worker sex no type were considered to be important in our study;
though there are significant differences between two countries—Belarus and Malawi—regard-
ing the population characteristics, such as the level of education, habitation, and health beliefs.
Latent class models are rarely used in health economics, though their merits are underesti-
mated [31]. In our study, the latent class model allowed to explore preferences to BCS attrib-
uted without complexity of models with individual heterogeneity. In a sensitivity analysis, we
also estimated preferences using the mixed-mixed logit model of De Blasi et al. (2010)[32],
which is a latent class logit model that accommodates preference heterogeneity within each
latent class. Hardly any heterogeneity was found within each of the latent classes, which con-
firmed our initial choice for a latent class logit model.
While our study applied a prudent approach to develop the DCE and analyse the results, it
has some limitations. Firstly, Belarus retains a commitment to the principle of universal access
to health care financed through taxation [30], thus including any cost components into the
survey implement potential perception bias, since some respondents may have difficulty to
imagine paying for services which they confidently know are free. Meanwhile, we considered
it necessary for costs to be a component of the DCE design to explore the potential of using
private healthcare facilities for BCS program. Secondly, the sample enrolment was conducted
in traumatology and burn departments of regional hospitals. Even though this strategy was
selected specifically because it was perceived as the least biased amongst other feasible
approaches, and there was no indication of bias in terms of difference among the respondents
Breast cancer screening preferences
PLOS ONE | https://doi.org/10.1371/journal.pone.0224667 November 1, 2019 14 / 17
by their habitation or education level, it is obviously not possible to rule out that the composi-
tion of the sample was not entirely representative of the overall population in other aspects.
Thirdly, our findings may be skewed towards more motivated sample because of the difference
in preferences of responders and non-responders.
Conclusions
Women in Belarus are heterogeneous in their preferences for screening. In general, they are
willing to trade off convenience factors in BCS organization for higher quality and cheaper
screening tests. Women also tend to prefer mammography as a screening method and largely
disregard the screening related harms. Meanwhile, women also prefer combined BCS to single
mammography, even though the clinical evidence does not support this modality. Policy mak-
ers should ensure proper communication to women regarding mammography accuracy as a
stand-alone screening approach.
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